These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 3330945)
1. [Immunoscintigraphy, an aid to the oncologist--the Rennes experience in using anti-CEA, anti-CA 19.9 monoclonal antibodies and radiolabelled OC-125]. Herry JY; Bourguet P; Kerbrat P; Le Prise E; Ben Hassel M; Gedouin D; Richier JL Allerg Immunol (Paris); 1987 May; 19(5):180-8. PubMed ID: 3330945 [TBL] [Abstract][Full Text] [Related]
2. Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies. Delaloye B; Bischof-Delaloye A; Buchegger F; von Fliedner V; Grob JP; Volant JC; Pettavel J; Mach JP J Clin Invest; 1986 Jan; 77(1):301-11. PubMed ID: 3484753 [TBL] [Abstract][Full Text] [Related]
3. Immunoscintigraphy of gastric or colon carcinoma with F(ab')2 fragments of anti-CEA monoclonal antibody. Amendolagine F; Allegra V; Tenti M; Lobrano V; Pannozzo G Rays; 1987; 12(1):67-71. PubMed ID: 3628863 [No Abstract] [Full Text] [Related]
4. Targeting of human breast cancer by a bispecific antibody directed against two tumour-associated antigens: ErbB-2 and carcinoembryonic antigen. Dorvillius M; Garambois V; Pourquier D; Gutowski M; Rouanet P; Mani JC; Pugnière M; Hynes NE; Pèlegrin A Tumour Biol; 2002; 23(6):337-47. PubMed ID: 12677091 [TBL] [Abstract][Full Text] [Related]
5. Anti-carcinoembryonic antigen immunoscintigraphy (technetium-99m-monoclonal antibody BW 431/26) and serum CEA levels in patients with suspected primary and recurrent colorectal carcinoma. Lind P; Lechner P; Arian-Schad K; Klimpfinger M; Cesnik H; Kammerhuber F; Eber O J Nucl Med; 1991 Jul; 32(7):1319-25. PubMed ID: 2066784 [TBL] [Abstract][Full Text] [Related]
6. Immunoscintigraphy with 99Tcm-labelled monoclonal anti-CEA BW 431/26 antibodies in patients with suspected recurrent and metastatic colorectal carcinoma: two-year follow-up. Lacić M; Bokulić T; Lukac J; Baum RP; Kusić Z Nucl Med Commun; 1999 Sep; 20(9):859-65. PubMed ID: 10533193 [TBL] [Abstract][Full Text] [Related]
8. Radioimmunoscintigraphy using monoclonal antibodies to CEA, CA 19-9 and CA 125. Baum RP; Lorenz M; Hottenrott C; Albrecht M; Senekowitsch R; Happ J; Hertel A; Spitz J; Hör G Int J Biol Markers; 1988; 3(3):177-84. PubMed ID: 3230337 [TBL] [Abstract][Full Text] [Related]
9. [Immunoscintigraphy of cancer of the ovaries and colon using labeled monoclonal antibodies]. Gabuniia RI; Shiriaev SV; Bogdasarov IuB; Zhordaniia KI; Anan'ev VS Med Radiol (Mosk); 1989 Aug; 34(8):56-61. PubMed ID: 2770446 [TBL] [Abstract][Full Text] [Related]
10. Immunoscintigraphy of colon carcinoma. Chatal JF; Saccavini JC; Fumoleau P; Douillard JY; Curtet C; Kremer M; Le Mevel B; Koprowski H J Nucl Med; 1984 Mar; 25(3):307-14. PubMed ID: 6366160 [TBL] [Abstract][Full Text] [Related]
11. Immunoscintigraphy of colorectal carcinoma with F (ab')2 fragments of anti-CEA monoclonal antibody. Buraggi G; Callegaro L; Turrin A; Gennari L; Bombardieri E; Mariani G; Deleide G; Dovis M; Gasparini M; Doci R Cancer Detect Prev; 1987; 10(5-6):335-45. PubMed ID: 3568032 [TBL] [Abstract][Full Text] [Related]
12. Tumor scintigraphy with 131I anti CEA monoclonal antibodies and F(ab')2 in colorectal cancer. Henze E; Kübel R; Waitzinger J; Büchler M; Adam WE; Beger HG Eur J Nucl Med; 1987; 13(3):125-9. PubMed ID: 3622555 [TBL] [Abstract][Full Text] [Related]
13. [Immunoscintigraphy using radio-labeled monoclonal antibodies. Development of a method of cancer diagnosis and hopes for a new form of therapy]. Mach JP; Bischof-Delaloye A; Curchod S; Studer A; Grob JP; Volant JC; Mosimann F; Givel JC; Douglas P; Leyvraz S Schweiz Med Wochenschr; 1987 Jul; 117(29):1076-86. PubMed ID: 3499666 [TBL] [Abstract][Full Text] [Related]
14. Immunoscintigraphy of primary and metastatic colorectal cancers with radiolabelled monoclonal antibodies anti-CEA. Riva P; Moscatelli G; Agostini M; Spinelli A; Franceschi G Acta Gastroenterol Belg; 1989; 52(5-6):497-505. PubMed ID: 2486018 [TBL] [Abstract][Full Text] [Related]
15. Clinical results of immunoscintigraphy in a variety of malignant tumors with special reference to immunohistochemistry. Biersack HJ; Bockisch A; Oehr P; Knoblich A; Hartlapp J; Biltz H; Jaeger N; Bellmann O; Vogel J; Björklund B Nuklearmedizin; 1986 Oct; 25(5):167-71. PubMed ID: 3540857 [TBL] [Abstract][Full Text] [Related]
16. Immunoscintigraphy using a technetium-99m labelled monoclonal anti-CEA antibody in the follow-up of colorectal cancer and other tumours producing CEA. Hertel A; Baum RP; Lorenz M; Baew-Christow T; Encke A; Hör G Br J Cancer Suppl; 1990 Jul; 10():34-6. PubMed ID: 2166552 [TBL] [Abstract][Full Text] [Related]
17. Metastatic colorectal cancer: radioimmunoscintigraphy with a stabilized In-111-labeled F(ab')2 fragment of an anti-CEA monoclonal antibody. Lamki LM; Patt YZ; Rosenblum MG; Shanken LJ; Thompson LB; Schweighardt SA; Frincke JM; Murray JL Radiology; 1990 Jan; 174(1):147-51. PubMed ID: 2294542 [TBL] [Abstract][Full Text] [Related]
18. [Localization of radiolabeled antibody to carcinoembryonic antigen in patients with gastrointestinal carcinoma]. Ohashi A Nihon Geka Gakkai Zasshi; 1986 Mar; 87(3):297-306. PubMed ID: 3713682 [TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies to carcinoembryonic antigen: ionic strength as a factor in the selection of antibodies for immunoscintigraphy. Haskell CM; Buchegger F; Schreyer M; Carrel S; Mach JP Cancer Res; 1983 Aug; 43(8):3857-64. PubMed ID: 6344991 [TBL] [Abstract][Full Text] [Related]